N

Noile-Immune Biotech Inc
TSE:4893

Watchlist Manager
Noile-Immune Biotech Inc
TSE:4893
Watchlist
Price: 156 JPY -2.5%
Market Cap: 6.8B JPY
Have any thoughts about
Noile-Immune Biotech Inc?
Write Note

Intrinsic Value

The intrinsic value of one Noile-Immune Biotech Inc stock under the Base Case scenario is 86.69 JPY. Compared to the current market price of 156 JPY, Noile-Immune Biotech Inc is Overvalued by 44%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
86.69 JPY
Overvaluation 44%
Intrinsic Value
Price
N
Worst Case
Base Case
Best Case

Valuation History
Noile-Immune Biotech Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Noile-Immune Biotech Inc
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for Noile-Immune Biotech Inc cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about Noile-Immune Biotech Inc?
Bearish
Neutral
Bullish

Fundamental Analysis

156 JPY
-2.5%
-2.5%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Noile-Immune Biotech Inc
JP
Biotechnology
Market Cap
6.8B JPY
IPO
Jun 28, 2023
Employees
-
Japan
Market Cap
6.8B JPY
Industry
Biotechnology
IPO
Jun 28, 2023
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Noile-Immune Biotech Inc

Provide an overview of the primary business activities
of Noile-Immune Biotech Inc.

What unique competitive advantages
does Noile-Immune Biotech Inc hold over its rivals?

What risks and challenges
does Noile-Immune Biotech Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Noile-Immune Biotech Inc.

Provide P/S
for Noile-Immune Biotech Inc.

Provide P/E
for Noile-Immune Biotech Inc.

Provide P/OCF
for Noile-Immune Biotech Inc.

Provide P/FCFE
for Noile-Immune Biotech Inc.

Provide P/B
for Noile-Immune Biotech Inc.

Provide EV/S
for Noile-Immune Biotech Inc.

Provide EV/GP
for Noile-Immune Biotech Inc.

Provide EV/EBITDA
for Noile-Immune Biotech Inc.

Provide EV/EBIT
for Noile-Immune Biotech Inc.

Provide EV/OCF
for Noile-Immune Biotech Inc.

Provide EV/FCFF
for Noile-Immune Biotech Inc.

Provide EV/IC
for Noile-Immune Biotech Inc.

Show me price targets
for Noile-Immune Biotech Inc made by professional analysts.

What are the Revenue projections
for Noile-Immune Biotech Inc?

How accurate were the past Revenue estimates
for Noile-Immune Biotech Inc?

What are the Net Income projections
for Noile-Immune Biotech Inc?

How accurate were the past Net Income estimates
for Noile-Immune Biotech Inc?

What are the EPS projections
for Noile-Immune Biotech Inc?

How accurate were the past EPS estimates
for Noile-Immune Biotech Inc?

What are the EBIT projections
for Noile-Immune Biotech Inc?

How accurate were the past EBIT estimates
for Noile-Immune Biotech Inc?

Compare the revenue forecasts
for Noile-Immune Biotech Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Noile-Immune Biotech Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Noile-Immune Biotech Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Noile-Immune Biotech Inc compared to its peers.

Compare the P/E ratios
of Noile-Immune Biotech Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Noile-Immune Biotech Inc with its peers.

Analyze the financial leverage
of Noile-Immune Biotech Inc compared to its main competitors.

Show all profitability ratios
for Noile-Immune Biotech Inc.

Provide ROE
for Noile-Immune Biotech Inc.

Provide ROA
for Noile-Immune Biotech Inc.

Provide ROIC
for Noile-Immune Biotech Inc.

Provide ROCE
for Noile-Immune Biotech Inc.

Provide Gross Margin
for Noile-Immune Biotech Inc.

Provide Operating Margin
for Noile-Immune Biotech Inc.

Provide Net Margin
for Noile-Immune Biotech Inc.

Provide FCF Margin
for Noile-Immune Biotech Inc.

Show all solvency ratios
for Noile-Immune Biotech Inc.

Provide D/E Ratio
for Noile-Immune Biotech Inc.

Provide D/A Ratio
for Noile-Immune Biotech Inc.

Provide Interest Coverage Ratio
for Noile-Immune Biotech Inc.

Provide Altman Z-Score Ratio
for Noile-Immune Biotech Inc.

Provide Quick Ratio
for Noile-Immune Biotech Inc.

Provide Current Ratio
for Noile-Immune Biotech Inc.

Provide Cash Ratio
for Noile-Immune Biotech Inc.

What is the historical Revenue growth
over the last 5 years for Noile-Immune Biotech Inc?

What is the historical Net Income growth
over the last 5 years for Noile-Immune Biotech Inc?

What is the current Free Cash Flow
of Noile-Immune Biotech Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Noile-Immune Biotech Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Noile-Immune Biotech Inc

Balance Sheet Decomposition
Noile-Immune Biotech Inc

Current Assets 4.9B
Cash & Short-Term Investments 4.7B
Receivables 192.5m
Other Current Assets 34.9m
Non-Current Assets 25.8m
Other Non-Current Assets 25.8m
Current Liabilities 62m
Accrued Liabilities 22.2m
Other Current Liabilities 39.8m
Non-Current Liabilities 5.2m
Other Non-Current Liabilities 5.2m
Efficiency

Earnings Waterfall
Noile-Immune Biotech Inc

Revenue
8.1m JPY
Cost of Revenue
-359k JPY
Gross Profit
7.8m JPY
Operating Expenses
-1.2B JPY
Operating Income
-1.2B JPY
Other Expenses
105.3m JPY
Net Income
-1.1B JPY

Free Cash Flow Analysis
Noile-Immune Biotech Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Noile-Immune Biotech Inc's profitability score is 22/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Revenue Growth Forecast
Negative 1-Year Revenue Growth
Negative ROE
22/100
Profitability
Score

Noile-Immune Biotech Inc's profitability score is 22/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Noile-Immune Biotech Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Noile-Immune Biotech Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Noile-Immune Biotech Inc

Wall Street analysts forecast Noile-Immune Biotech Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Noile-Immune Biotech Inc is 448.8 JPY with a low forecast of 444.4 JPY and a high forecast of 462 JPY.

Lowest
Price Target
444.4 JPY
185% Upside
Average
Price Target
448.8 JPY
188% Upside
Highest
Price Target
462 JPY
196% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Noile-Immune Biotech Inc?

Click here to dive deeper.

Dividends

Noile-Immune Biotech Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for Noile-Immune Biotech Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one Noile-Immune Biotech Inc stock?

The intrinsic value of one Noile-Immune Biotech Inc stock under the Base Case scenario is 86.69 JPY.

Is Noile-Immune Biotech Inc stock undervalued or overvalued?

Compared to the current market price of 156 JPY, Noile-Immune Biotech Inc is Overvalued by 44%.

Back to Top